[KTTA] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
13-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 22.40%
YoY- 16.97%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 0 0 219 0 0 -
PBT -3,000 -3,613 -4,191 -1,526 -14 282.25%
Tax 0 -162 730 0 0 -
NP -3,000 -3,613 -4,586 -1,526 -14 282.25%
Tax Rate - - - - - -
Total Cost 3,000 3,613 4,805 1,526 14 282.25%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin 0.00 0.00 -2,097.88 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -2.87 -2.87 -3.45 -0.17 -0.00 -
EPS Diluted -2.87 -2.87 -3.45 -0.17 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.